US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.500 +0.290 (+9.03%)
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Recap: Prime Medicine Q4 Earnings ↗
 
Via Benzinga
News headline image
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday! 
Via InvestorPlace
News headline image
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
2 Magnificent Growth Stocks With Room to Run ↗
These deeply undervalued growth stocks could be big winners for patient shareholders. 
Via The Motley Fool
News headline image
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging ↗
Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio. 
Via InvestorPlace
News headline image
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks. 
Via InvestorPlace
News headline image
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Announces Pricing of Upsized Public Offering
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Announces Proposed Public Offering of Common Stock
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
2 gene editing stocks to keep on your 2024 watchlist
Gene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) 
Via MarketBeat
News headline image
Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones index falling more than 250 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. 
Via Benzinga
News headline image
Better Growth Stock: Archer Aviation or Prime Medicine? ↗
Which of these innovation-themed growth stocks is the better buy? 
Via The Motley Fool
News headline image
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. ↗
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach. 
Via The Motley Fool
News headline image
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years ↗
This gene-editing company could sport a best-in-class platform. 
Via The Motley Fool
News headline image
Prime Medicine to Present at Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >